Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
Bojana Beović, May Doušak, João Ferreira‐Coimbra, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 75, Iss. 11, pp. 3386-3390
Open Access | Times Cited: 253

Showing 1-25 of 253 citing articles:

How Antimicrobial Resistance Is Linked to Climate Change: An Overview of Two Intertwined Global Challenges
Roberta Magnano San Lio, Giuliana Favara, Andrea Maugeri, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1681-1681
Open Access | Times Cited: 333
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
Dominique L Monnet, Stephan Harbarth
Eurosurveillance (2020) Vol. 25, Iss. 45
Open Access | Times Cited: 163
Antimicrobial resistance in long-term care facilities
N Eze, Michele Cecchini, Tiago Cravo Oliveira Hashiguchi
OECD health working papers (2022)
Open Access | Times Cited: 154
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
Marco Falcone, Giusy Tiseo, Cesira Giordano, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 4, pp. 1078-1084
Open Access | Times Cited: 142
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, et al.
Tropical Medicine and Health (2021) Vol. 49, Iss. 1
Open Access | Times Cited: 112
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome
Carter Merenstein, Guanxiang Liang, Samantha A. Whiteside, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 101
COVID-19 pneumonia and the appropriate use of antibiotics
Amy Sarah Ginsburg, Keith P. Klugman
The Lancet Global Health (2020) Vol. 8, Iss. 12, pp. e1453-e1454
Open Access | Times Cited: 120
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 99
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Jesús Rodríguez‐Baño, Gian María Rossolini, Constance Schultsz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 10, pp. 1122-1129
Open Access | Times Cited: 90
Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic
Santiago Grau, Daniel Echeverría-Esnal, Sílvia Gómez-Zorrilla, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 132-132
Open Access | Times Cited: 81
Rationale for azithromycin in COVID-19: an overview of existing evidence
Iwein Gyselinck, Wim Janssens, Peter Verhamme, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e000806-e000806
Open Access | Times Cited: 72
The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid)
Guido Granata, Alessandro Bartoloni, Mauro Codeluppi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3855-3855
Open Access | Times Cited: 69
Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review
Wenjuan Cong, Ak Narayan Poudel, Nour Alhusein, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 745-745
Open Access | Times Cited: 69
Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19
Anas Baiou, Abdurrahmaan Ali Suei Elbuzidi, Dana Bakdach, et al.
Journal of Hospital Infection (2021) Vol. 110, pp. 165-171
Open Access | Times Cited: 64
COVID-19 and Antimicrobial Resistance: A Review
Yusuff Adebayo Adebisi, Aishat Jumoke Alaran, Melody Okereke, et al.
Infectious Diseases Research and Treatment (2021) Vol. 14
Open Access | Times Cited: 64
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
Alejandro David Bendala Estrada, Jorge Calderón‐Parra, Eduardo Fernández Carracedo, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 58
The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review
Sara H. Al-Hadidi, Hashim Alhussain, Hamad Abdel Hadi, et al.
Microbial Drug Resistance (2021) Vol. 27, Iss. 12, pp. 1705-1725
Open Access | Times Cited: 55
Respiratory tract infections and gut microbiome modifications: A systematic review
Claire A. Woodall, Luke J. McGeoch, Alastair D Hay, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262057-e0262057
Open Access | Times Cited: 42
Construction of hydrostable cesium lead bromide-titania for visible-light degradation of tetracycline hydrochloride in water
Chunxi Liu, Xiaoxiao Qian, Qiyan Wei, et al.
Journal of Cleaner Production (2022) Vol. 365, pp. 132830-132830
Closed Access | Times Cited: 38
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020
Nikolina Bogdanić, Loris Močibob, Toni Vidović, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263437-e0263437
Open Access | Times Cited: 37
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial
Muriel Fartoukh, Saad Nseir, Bruno Mégarbane, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 734-743
Open Access | Times Cited: 21
Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020
Amelia Andrews, Emma Budd, Aoife Hendrick, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 841-841
Open Access | Times Cited: 54
Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
Ayukafangha Etando, Adefolarin A. Amu, Mainul Haque, et al.
Healthcare (2021) Vol. 9, Iss. 12, pp. 1722-1722
Open Access | Times Cited: 52
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings
Rosario Cultrera, Agostino Barozzi, Marco Libanore, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 8, pp. 4358-4358
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top